ADHD

The Pharmacy Times® Attention-Deficit Hyperactivity Disorder (ADHD) Resource Center is a comprehensive resource for clinical news and expert insights on issues related to ADHD, a chronic condition that can cause attention difficulty, hyperactivity, and impulsiveness.

Latest News

Image Credit: © Syuzann q - stock.adobe.com
The Lost Girls: Unmasking ADHD in Adult Women

October 29th 2024

Evolving understanding of attention deficit hyperactivity disorder (ADHD) underscores the need for inclusive research and support, especially for women.

Image Credit: © Alexis Scholtz/peopleimages.com - stock.adobe.com
Researchers Identify Links Between Gut Microbiome and Autism, Potentially Paving the Way for New Diagnostics

July 12th 2024

Young boy with ADHD -- Image credit: Photographee.eu | stock.adobe.com
Study Finds Relative Age Effect on ADHD Diagnosis and Prescription of Medication in Children

June 20th 2024

autism gene expression/ Image Credits: © Prostock-studio - stock.adobe.com
Understanding the Connection Between Genetic Risk and Brain Cell Activity in Autism Spectrum Disorder

June 6th 2024

FDA approval stamp -- Image credit: Surendra | stock.adobe.com
FDA Approves Clonidine Hydrochloride For Treatment of ADHD in Pediatric Patients

May 29th 2024

More News

Site Logo

Top 200 Drugs of 2011

Michael Bartholow, PharmD, CACP
July 10th 2012

An analysis of the top 200 drugs by prescriptions dispensed and total sales reveals key trends in today's pharmaceutical market.

Read More

Site Logo

Asperger's Syndrome: Early Detection Helps

Charles H. Brown, MSPharm, RPh, CACP
March 21st 2012

The wider range of symptoms found in Asperger's syndrome makes the disorder a challenge to diagnose and treat.

Read More

Playing the Blame Game over Shortages of ADHD Drugs

Playing the Blame Game over Shortages of ADHD Drugs

January 30th 2012

As manufacturers and government agencies squabble over quotas, patients scramble to get their preferred treatment regimens.

Read More

Site Logo

Heart Health Watch

December 12th 2011

Read More

New Guidelines Expand the Scope of ADHD

New Guidelines Expand the Scope of ADHD

Kate H. Gamble, Senior Editor
October 18th 2011

Updated recommendations from the AAP provide guidance on treatment of ADHD in different age groups, and emphasize the importance of behavioral therapy.

Read More

Site Logo

Shionogi Pharma's Kapvay

Caryn Belisle, RPh, Alka Patel, PharmD;Nicole Russo, PharmD Candidate
March 14th 2011

The FDA approved Kapvay (clonidine hydrochloride extended -release) as a monotherapy and adjunctive therapy for the treatment of attention- deficit/hyperactivity disorder in children and adolescents aged 6 to 17 years.

Read More

<123456